Earnings release
Page 1
Exhibit 99.1 InMode Reports Second Quarter 2026 Financial Results : Quarterly GAAP Revenues of $ 95.6 Million , Consistent with the Second Quarter of 2025 YOKNEAM , Israel , August 5 , 2026 - InMode Ltd. ( Nasdaq : INMD ) ( “ InMode ” ) , a leading global provider of innovative medical technologies , today announced its consolidated financial results for the second quarter of 2026 . Second Quarter 2026 Highlights : Quarterly GAAP revenues of $ 95.6 million , consistent with the second quarter of 2025 . 2025 . Quarterly revenues from consumables and service of $ 22.3 million , an increase of 13 % compared to the second quarter of GAAP operating income of $ 12.3 million and * non - GAAP operating income of $ 16.0 million . Total cash position of $ 501.1 million as of June 30 , 2026 , including cash and cash equivalents , marketable securities and short - term bank deposits . Completed the repurchase of 6.38 million ordinary shares for an aggregate purchase price of $ 87.8 million through the previously announced share repurchase program . U.S. GAAP Results ( U.S. dollars in thousands , except for per share data ) Q2 2026 Q2 2025 $ 95,589 $ 95,602 Revenues Gross Margins Operating Margins Net Income Earnings per Diluted Share 75 % 13 % $ 17,064 $ 0.29 * Non - GAAP Results ( U.S. dollars in thousands , except : for per share data ) 80 % 24 % $ 26,742 $ 0.42 Gross Margins Operating Margins Net Income Earnings per Diluted Share Q2 2026 75 % 17 % $ 20,812 $ 0.35 Q2 2025 80 % 28 % $ 30,139 $ 0.47 * Please refer to " Use of non - GAAP Financial Measures " below for important information about non - GAAP financial measures . A reconciliation between U.S. GAAP and non - GAAP Statement of Income is provided following the financial statements included in this release . Non - GAAP results exclude share - based compensation , expenses related to independent transaction committee review ( representing non - recurring cost ) and related income tax adjustments where applicable . Management Comments “ Overall revenue was consistent with the prior - year period , and we saw continued stability in our U.S. capital equipment business , reflecting steady customer demand . This performance is consistent with the stabilization we anticipate will continue through the remainder of the year . We remain focused on investing in opportunities that support long - term growth , ” said Moshik Itzkovich , Chief Financial Officer of InMode . Second Quarter 2026 Financial Results Total GAAP revenues for the second quarter of 2026 were $ 95.6 million , consistent with the second quarter of 2025. Revenue from Asia reached a quarterly record , reflecting continued strength across key markets in the region . Quarterly revenues from consumables and service grew 13 % compared to the second quarter of 2025 , to $ 22.3 million , derived primarily from international sales .
Page 2
GAAP gross margin for the second quarter of 2026 was 75%, compared to 80% for the second quarter of 2025. *Non-GAAP gross margin for the second quarter of 2026 was 75%, compared to 80% for the second quarter of 2025. GAAP operating margin for the second quarter of 2026 was 13%, compared to 24% for the second quarter of 2025. *Non-GAAP operating margin for the second quarter of 2026 was 17%, compared to 28% for the second quarter of 2025. These decreases were primarily attributable to higher cost of goods sold, product mix, the restructuring of the North America sales team implemented toward the end of 2025, additional marketing and sales investments to retain talent and maintain market share, and higher general and administrative expenses driven by increased professional services costs. We expect these trends to continue for the foreseeable future. InMode reported GAAP net income of $17.1 million, or $0.29 per diluted share, in the second quarter of 2026, compared to $26.7 million, or $0.42 per diluted share, in the second quarter of 2025. On a *non-GAAP basis, InMode reported net income of $20.8 million, or $0.35 per diluted share, in the second quarter of 2026, compared to $30.1 million, or $0.47 per diluted share, in the second quarter of 2025. As of June 30, 2026, InMode had cash and cash equivalents, marketable securities and short-term bank deposits of $501.1 million. Appointed New Chief Financial Officer and New Board Director On May 20, 2026, the Company announced the appointment of Dr. Shlomo Nass as its new Chairman of the Company’s Board of Directors, effective May 19, 2026. The Company also announced the appointment of Moshe (Moshik) Itzkovich as the Company’s new Chief Financial Officer, effective May 19, 2026, while former Chief Financial Officer Yair Malca continues to be engaged with the Company as a consultant. 2026 Financial Outlook Management provided an outlook for the full fiscal year ending December 31, 2026. Based on current estimates, management expects: ● Revenues between $365 million and $375 million ● *Non-GAAP gross margin between 74% and 76% ● *Non-GAAP income from operations to be between $68 million and $73 million ● *Non-GAAP earnings per diluted share between $1.29 and $1.34 However, these expectations are based on management’s current estimates, which may be updated. This outlook is not a guarantee of future performance, and shareholders should not rely on such forward-looking statements. See “Forward-Looking Statements” for additional information. *Please refer to “Use of non-GAAP Financial Measures” below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided following the financial statements that are included in this release. Non-GAAP results exclude share-based compensation, expenses related to independent transaction committee review (representing non-recurring cost) and related income tax adjustments where applicable. Conference Call and Webcast Update As previously announced, while the Company’s Special Committee continues its evaluation of unsolicited proposals, the Company will not host an investor conference call or webcast in connection with this earnings release and will not be conducting investor meetings at this time.
Page 3
The Current Situation in Israel The scope and severity of ongoing conflicts in Gaza, Northern Israel, Lebanon, Iran, and the broader region are unpredictable and could escalate at any time. To date, our operations have not been materially affected. We continue to monitor political and military developments closely and examine the consequences for our operations and assets. Use of Non-GAAP Financial Measures In addition to InMode’s operating results presented in accordance with GAAP, this release contains certain non-GAAP financial measures including non-GAAP net income, non-GAAP earnings per diluted share, non-GAAP operating margin, non-GAAP gross margin and non- GAAP income from operations. Because these measures are used in InMode’s internal analysis of financial and operating performance, management believes they provide investors with greater transparency into its view of InMode’s economic performance. Management also believes the presentation of these measures, when analyzed in conjunction with InMode’s GAAP operating results, allows investors to more effectively evaluate and compare InMode’s performance to that of its peers, although InMode’s presentation of its non-GAAP measures may not be strictly comparable to the similarly titled measures of other companies. Schedules reconciling each of these non- GAAP financial measures are provided as a supplement to this release. Reconciliations of non-GAAP gross margin, non-GAAP income from operations, and non-GAAP earnings per diluted share for management’s projections of such non-GAAP financials for the 2026 fiscal year are not available without unreasonable effort due to the variability, complexity and limited visibility of certain reconciling items. These reconciling items could have a significant and unpredictable impact on our future GAAP results. About InMode InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency (“RF”) technology. InMode strives to enable emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com. Forward-Looking Statements The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode’s future financial or operating performance, including the actual amount of share repurchases made by the Company, if any. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” “would” and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management’s current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode’s Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2026, and our subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release. Company Contact: Moshik Itzkovich Chief Financial Officer Email: Moshik.Itzkovich@inmodemd.com Investor Relations Contact: Miri Segal MS-IR LLC Email: ir@inmodemd.com
Page 4
INMODE LTD. CONDENSED CONSOLIDATED STATEMENTS OF INCOME (U.S. dollars in thousands, except for per share data) (Unaudited) Three months ended Six months ended June 30, June 30, 2026 2025 2026 2025 REVENUES 95,589 95,602 177,606 173,476 COST OF REVENUES 24,073 19,152 44,538 36,115 GROSS PROFIT 71,516 76,450 133,068 137,361 OPERATING EXPENSES: Research and development 3,656 3,372 7,198 6,267 Sales and marketing 50,818 47,474 93,750 87,201 General and administrative 4,785 2,723 9,807 5,394 TOTAL OPERATING EXPENSES 59,259 53,569 110,755 98,862 OPERATING INCOME 12,257 22,881 22,313 38,499 Finance income, net 7,432 8,062 11,728 14,921 INCOME BEFORE INCOME TAXES 19,689 30,943 34,041 53,420 INCOME TAXES 2,625 4,201 5,415 8,477 NET INCOME 17,064 26,742 28,626 44,943 EARNINGS PER SHARE: Basic 0.29 0.42 0.47 0.68 Diluted 0.29 0.42 0.46 0.68 WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF EARNINGS PER SHARE (in thousands) Basic 58,903 63,252 61,140 65,982 Diluted 59,378 63,637 61,717 66,540
Page 5
INMODE LTD. CONDENSED CONSOLIDATED BALANCE SHEETS (U.S. dollars in thousands, except for per share data) (Unaudited) June 30, 2026 December 31, 2025 Assets CURRENT ASSETS: Cash and cash equivalents 396,173 302,543 Marketable securities 18,995 83,632 Short-term bank deposits 85,947 169,159 Accounts receivable, net of allowance for credit losses 44,555 43,504 Prepaid expenses and other receivables 32,664 25,733 Inventories 71,661 74,050 TOTAL CURRENT ASSETS 649,995 698,621 NON-CURRENT ASSETS: Accounts receivable, net of allowance for credit losses 5,686 3,005 Deferred income tax assets 52,629 53,230 Operating lease right-of-use assets 8,693 8,274 Property and equipment, net 2,628 2,599 Other investments 700 700 TOTAL NON-CURRENT ASSETS 70,336 67,808 TOTAL ASSETS 720,331 766,429 Liabilities and shareholders’ equity CURRENT LIABILITIES: Accounts payables 18,792 17,912 Contract liabilities 15,452 12,093 Other liabilities 45,193 40,739 TOTAL CURRENT LIABILITIES 79,437 70,744 NON-CURRENT LIABILITIES: Contract liabilities 2,484 3,043 Other liabilities 4,825 4,436 Operating lease liabilities 4,451 5,008 TOTAL NON-CURRENT LIABILITIES 11,760 12,487 TOTAL LIABILITIES 91,197 83,231 TOTAL SHAREHOLDERS’ EQUITY 629,134 683,198 TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY 720,331 766,429
Page 6
INMODE LTD. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (U.S. dollars in thousands, except for per share data) (Unaudited) Three months ended June 30, Six months ended June 30, 2026 2025 2026 2025 CASH FLOWS FROM OPERATING ACTIVITIES: Net income 17,064 26,742 28,626 44,943 Adjustments required to reconcile net income to net cash provided by operating activities: Depreciation and amortization 179 191 354 365 Share-based compensation expenses 3,708 3,418 6,407 5,936 Change in allowance for credit losses of trade receivable 719 147 1,244 53 Loss on marketable securities, net ‐ 5 ‐ 3 Finance expenses (income), net 388 (313) 1,107 (1,887) Deferred income taxes 295 566 622 1,462 Changes in operating assets and liabilities: Decrease (increase) in accounts receivable (current and non- current) (5,046) (3,285) (4,974) 1,259 Decrease (increase) in other receivables (1,164) 1,276 (7,030) (2,256) Decrease (increase) in inventories (253) (4,329) 2,389 (8,562) Increase in accounts payable 1,939 2,430 880 3,700 Increase (decrease) in other liabilities (current and non-current) 4,400 127 4,012 (3,160) Increase (decrease) in contract liabilities (current and non-current) (1,178) (2,903) 2,800 (3,740) Net cash provided by operating activities 21,051 24,072 36,437 38,116 CASH FLOWS FROM INVESTING ACTIVITIES: Investment in short-term deposits (85,000) (25,000) (169,912) (25,000) Proceeds from short-term deposits 84,912 55,000 252,570 86,297 Purchase of fixed assets (211) (219) (383) (304) Purchase of marketable securities ‐ - (9,727) (20,877) Proceeds from sale of marketable securities ‐ - ‐ 3,003 Proceeds from maturity of marketable securities 37,983 41,875 74,239 104,022 Net cash provided by investing activities 37,684 71,656 146,787 147,141 CASH FLOWS FROM FINANCING ACTIVITIES: Tax withholding related to vesting of restricted share units - - (1,802) - Repurchase of ordinary shares (56,511) (27,484) (87,752) (127,444) Exercise of options 19 505 636 999 Net cash used in financing activities (56,492) (26,979) (88,918) (126,445) EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS (365) 1,540 (676) 2,096 NET INCREASE IN CASH AND CASH EQUIVALENTS 1,878 70,289 93,630 60,908 CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 394,295 145,948 302,543 155,329 CASH AND CASH EQUIVALENTS AT END OF PERIOD 396,173 216,237 396,173 216,237
Page 7
INMODE LTD. CONDENSED CONSOLIDATED FINANCIAL HIGHLIGHTS (U.S. dollars in thousands, except for per share data) (Unaudited) Three months ended June 30, Six months ended June 30, 2026 2025 2026 2025 Revenues by Category: Capital Equipment revenues - United States 43,084 45% 40,653 42% 76,753 43% 70,195 40% Capital Equipment revenues - International 30,194 32% 35,133 37% 57,179 32% 63,266 37% Total Capital Equipment revenues 73,278 77% 75,786 79% 133,932 75% 133,461 77% Consumables and service revenues 22,311 23% 19,816 21% 43,674 25% 40,015 23% Total Revenue 95,589 100% 95,602 100% 177,606 100% 173,476 100% Three months ended June 30, Six months ended June 30, 2026 2025 2026 2025 % % % % United States International Total United States International Total United States International Total United States International Total Revenues by Technology: Minimal- Invasive 71 73 73 73 82 78 73 77 75 82 81 81 Hands-Free 1 2 1 4 2 3 1 1 1 3 2 3 Non-Invasive 28 25 26 23 16 19 26 22 24 15 17 16 100 100 100 100 100 100 100 100 100 100 100 100
Page 8
INMODE LTD. RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME TO NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME (U.S. dollars in thousands, except for per share data) (Unaudited) Three months ended June 30, 2026 Three months ended June 30, 2025 GAAP Stock Based Compensation Non-GAAP GAAP Stock Based Compensation Non-GAAP REVENUES 95,589 ‐ 95,589 95,602 ‐ 95,602 COST OF REVENUES 24,073 (302) 23,771 19,152 (334) 18,818 GROSS PROFIT 71,516 302 71,818 76,450 334 76,784 OPERATING EXPENSES: Research and development 3,656 (282) 3,374 3,372 (287) 3,085 Sales and marketing 50,818 (2,525) 48,293 47,474 (2,529) 44,945 General and administrative 4,785 (599) 4,186 2,723 (268) 2,455 TOTAL OPERATING EXPENSES 59,259 (3,406) 55,853 53,569 (3,084) 50,485 OPERATING INCOME 12,257 3,708 15,965 22,881 3,418 26,299 Finance income, net 7,432 ‐ 7,432 8,062 - 8,062 INCOME BEFORE INCOME TAXES 19,689 3,708 23,397 30,943 3,418 34,361 INCOME TAXES 2,625 (40) 2,585 4,201 21 4,222 NET INCOME 17,064 3,748 20,812 26,742 3,397 30,139 EARNINGS PER SHARE Basic 0.29 0.35 0.42 0.48 Diluted 0.29 0.35 0.42 0.47 WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF NET INCOME PER SHARE (in Thousands) Basic 58,903 58,903 63,252 63,252 Diluted 59,378 60,174 63,637 64,537
Page 9
Six months ended June 30, 2026 Six months ended June 30, 2025 GAAP Stock Based Compensation Expenses Related to Independent Transaction Committee Review Non- GAAP GAAP Stock Based Compensation Non-GAAP REVENUES 177,606 ‐ ‐ 177,606 173,476 - 173,476 COST OF REVENUES 44,538 (616) ‐ 43,922 36,115 (644) 35,471 GROSS PROFIT 133,068 616 ‐ 133,684 137,361 644 138,005 OPERATING EXPENSES: Research and development 7,198 (550) ‐ 6,648 6,267 (509) 5,758 Sales and marketing 93,750 (4,386) ‐ 89,364 87,201 (4,292) 82,909 General and administrative 9,807 (855) (1,262) 7,690 5,394 (491) 4,903 TOTAL OPERATING EXPENSES 110,755 (5,791) (1,262) 103,702 98,862 (5,292) 93,570 OPERATING INCOME 22,313 6,407 1,262 29,982 38,499 5,936 44,435 Finance income, net 11,728 ‐ ‐ 11,728 14,921 - 14,921 INCOME BEFORE INCOME TAXES 34,041 6,407 1,262 41,710 53,420 5,936 59,356 INCOME TAXES 5,415 (389) ‐ 5,026 8,477 (655) 7,822 NET INCOME 28,626 6,796 1,262 36,684 44,943 6,591 51,534 EARNINGS PER SHARE Basic 0.47 0.60 0.68 0.78 Diluted 0.46 0.59 0.68 0.77 WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF NET INCOME PER SHARE (in Thousands) Basic 61,140 61,140 65,982 65,982 Diluted 61,717 62,324 66,540 67,052